| Metric | Value ($ M) | Q2 FY25 | Q3 FY24 |
|---|---|---|---|
| Revenue | 3.44 | 27.4% | 5.5% |
| Total Income | 3.44 | 27.4% | 5.5% |
| Expenditure | 12.36 | 0.6% | 15.4% |
| PBT | -11.02 | 19.4% | 6.7% |
| Net Profit | -11.02 | 19.4% | 6.7% |
| OPM | — | ||
| NPM | — | ||
| EPS | -0.14 | 16.7% | 0.0% |
Hyperfine, Inc. Reports Q3 2025 Revenue $3.4 Million, Up 27% QoQ
04 May 2026 · 4 May, 7:14 am
Summary
Hyperfine, Inc. announced its third quarter 2025 financial results, reporting revenues of $3.4 million, a 27% increase compared to the second quarter of 2025. The gross margin for the quarter was $1.8 million, representing a 53.8% gross margin, a record for the company. Net loss for the third quarter was $11.0 million, or $0.14 per share. Management expects revenue for the fourth quarter of 2025 to be approximately $5 to $6 million, and full year 2025 revenue is expected to be approximately $13 to $14 million.
Key Highlights
- 1
Hyperfine, Inc. reported third quarter 2025 revenues of $3.4 million, a 27% increase compared to the second quarter of 2025.
- 2
The company sold 8 commercial Swoop® systems in the third quarter of 2025, with 5 being next generation Swoop® systems.
- 3
Gross margin for the third quarter of 2025 was $1.8 million, representing a 53.8% gross margin, a record quarter and up 450 basis points compared to the second quarter of 2025.
- 4
Net loss for the third quarter of 2025 was $11.0 million, or $0.14 per share, compared to a net loss of $9.2 million, or $0.12 per share, for the second quarter of 2025.
- 5
The company raised $20.1 million in gross proceeds through an underwritten public offering in October 2025.
- 6
Management expects revenue for the fourth quarter of 2025 to be approximately $5 to $6 million, representing sequential and year-over-year quarterly growth of 60% and 137%, respectively.
- 7
Full year 2025 revenue is now expected to be approximately $13 to $14 million.
Management Comments
Maria Sainz
“In the third quarter, we began to reap the benefits of two key growth catalysts with the launches of our next generation Swoop® system and Optive AITM software and our entrance into the neurology office market. Feedback from the first 100 days following the launch of our next generation Swoop® system bolsters our belief that this system will drive broad-based adoption of our portable Swoop® system across multiple sites of care, diversifying and accelerating our growth and improving our financial performance.”
Informational and educational content only. Not investment advice.